Showing results (201-210 of 207) with videos related to
Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
Primary Care Diabetes|January 28, 2023
Consensus of Chinese experts on strengthening personalized prevention and treatment of type 2 diabetesBin Lu, Jianqin Sun, Lili Chen, et al.Science Bulletin|January 19, 2023
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS)Weiping Jia, Jianhua Ma, Heng Miao, et al.Nature Medicine|May 13, 2022
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialDalong Zhu, Xiaoying Li, Jianhua Ma, et al.Journal of Evidence-Based Medicine|November 12, 2024
Chinese expert consensus on the management of hypertension in adults with type 2 diabetesXiaohui Pan, Hongbo He, Yuqian Bao, et al.Diabetologia|November 21, 2025
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trialDalong Zhu, Jianhua Ma, Weimin Wang, et al.Science China. Life Sciences|May 27, 2016
The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patientsJin Liu, Lingling Bian, Li Ji, et al.Nature Medicine|May 13, 2022
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialWenying Yang, Dalong Zhu, Shenglian Gan, et al.Pageof 21